Drugs / Td5ap
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00870350 Comparator | Apr → Oct 2009 | diphtheria, pertussis, tetanus | Swedish Institute for Infectious Disease Control | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Td5ap | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00870350 ↗ |
| Modality | Vaccine | “The vaccines in the study are COVAXIS (Td5ap), Sanofi Pasteur Canada” NCT00870350 ↗ |
| Route | Intramuscular | “Intramuscular injection of 0.5 mL Td5ap (COVAXiS) on day 1.” NCT00870350 ↗ |